Personalized Medical Care & Dedicated International Patient Concierge

4.9 Patient Satisfaction

en-US

Medical Clinic LogoMedical ClinicHome
Book Consultation
Book Consultation
Patient Guide
SpecialtiesServicesDoctorsOffersArticlesBefore & AfterReviewsAbout UsContact Us
How Physicians Determine Candidacy for Stem Cell Therapy

Medical Guide

How Physicians Determine Candidacy for Stem Cell Therapy

How physicians determine stem cell therapy candidacy criteria: the diagnostic evaluation, lab testing, and contraindications that decide who qualifies.

Schedule a Consultation

How Physicians Determine Candidacy for Stem Cell Therapy: The Diagnostic Criteria Explained

Medically reviewed by Dr. Seok Lee, Lead Physician, Pentaheal Medical Group

If you are exploring regenerative medicine, one of the first questions worth asking is a practical one: how do physicians actually decide who is a good fit? Understanding stem cell therapy candidacy criteria matters because eligibility is never assumed. It is determined through a careful, step-by-step clinical process that combines a physician evaluation with laboratory testing. At Pentaheal Medical Group in the Seocho District of Seoul, South Korea, candidacy is treated as a medical decision rather than a checkbox, and every plan is built around what your individual assessment reveals. This article explains that process in plain terms so you know what to expect before you ever schedule a consultation.

It is important to be clear from the start about the regulatory context. Regenerative and mesenchymal stem cell (MSC) therapies are not approved by the U.S. Food and Drug Administration (FDA) for effectiveness in treating the kinds of conditions discussed here. Pentaheal Medical Group operates within South Korea's regulatory framework for regenerative medicine and is registered with the Ministry of Health and Welfare to care for foreign patients. These are Korean designations and are not equivalent to U.S. FDA approval. The clinic's own language about these therapies is deliberately exploratory: cells are described as being studied for their potential to support tissue repair, and outcomes are never guaranteed. Individual results vary.

Why Candidacy Is Decided Case by Case

Regenerative medicine is not a one-size-fits-all service, and that is precisely why a screening process exists. Two people with similar symptoms can have very different underlying biology, medication histories, and risk profiles. Determining who qualifies for stem cell therapy therefore depends on more than a single symptom or a single scan. It depends on a full picture of your health.

Pentaheal Medical Group describes its approach as diagnostics-first. Rather than starting with a treatment and working backward, the clinic starts with a thorough evaluation and lets the findings guide whether a regenerative approach is appropriate at all. The clinic states that this method is informed by its experience analyzing more than 100,000 patient cases and is delivered through a 1:1 physician care model, meaning the physician who evaluates you stays involved throughout your care. You can learn more about this philosophy on the clinic's main information page.

The Documented Three-Step Diagnostic Model

At the center of candidacy assessment is a documented three-step diagnostic model. Each step builds on the last, and no treatment decision is made until all three are complete.

Step 1: Functional Health Evaluation

The process begins with a functional health evaluation led by a physician. This is a detailed conversation and examination that reviews your medical history, current symptoms, lifestyle factors, medications, and any previous treatments you have tried. The goal is to understand the root causes of your concerns rather than only the surface symptoms. This first step also flags anything that would require closer scrutiny before proceeding, such as a history of certain illnesses or medications that affect bleeding or immune function.

Step 2: Precision Diagnostic Testing

The second step is precision diagnostic testing. This is where objective laboratory data enters the picture, and it is central to how stem cell therapy eligibility is established. Pentaheal Medical Group's documented testing looks across several dimensions of your physiology:

  • Metabolic imbalances, which may include how your body processes energy and nutrients
  • Nutritional deficiencies that could affect healing and recovery
  • Hormonal irregularities that influence tissue function and overall vitality
  • Environmental toxin exposure, which can contribute to chronic symptoms
  • Inflammatory responses, measured through inflammatory markers

Depending on your situation, testing may include blood and urine analysis, organic acid metabolic analysis, hormone profiling, inflammatory marker testing, food-sensitivity testing, and imaging studies such as X-ray or bone-density scanning when indicated. These tests do more than describe your health; they help the physician judge whether a regenerative approach is reasonable and, just as importantly, whether it would be unsafe.

Step 3: Personalized Treatment Planning

The third step is personalized regenerative treatment planning. Here the physician integrates everything learned in the first two steps into a coherent plan tailored to your diagnostic findings and health goals. For some people, that plan may include a regenerative therapy. For others, the same findings may point toward metabolic support, nutritional therapy, rehabilitation, or a different path entirely. The plan is a recommendation grounded in your data, not a predetermined package.

Conditions Physicians Consider for Regenerative Care

Certain categories of concern are the ones most commonly evaluated for regenerative therapy. According to Pentaheal Medical Group, adults who may be considered candidates, after physician evaluation, include those with:

  • Degenerative joint or musculoskeletal conditions, such as age-related joint wear
  • Chronic inflammation or persistent pain that has not resolved with other measures
  • Tissue damage or age-related functional decline
  • Recovery needs after injury or surgery where regenerative support is being explored
  • Inflammatory or autoimmune-related conditions, considered strictly on a case-by-case basis
  • Persistent fatigue or metabolic dysfunction as part of a physician-directed plan
  • Limited improvement with conventional treatments, prompting a look at individualized options

Being in one of these categories does not by itself confirm eligibility. It simply means your situation is the type that a physician may reasonably assess. The three-step evaluation still determines whether treatment is appropriate for you specifically.

Contraindications: When Regenerative Therapy May Not Be Appropriate

Just as important as knowing who may qualify is knowing when a regenerative approach should not proceed. Screening for contraindications is one of the most important safety functions of the candidacy process, and Pentaheal Medical Group documents several conditions that may make someone unsuitable. These deserve prominent attention:

  • Active cancer, or a history of cancer that requires further evaluation. Because stem cells are biologically active, any active or unresolved cancer concern calls for careful review before treatment is considered.
  • Severe active infections. An active infection generally needs to be resolved and stabilized first.
  • Certain autoimmune conditions during an acute flare. Autoimmune-related conditions may be considered case by case, but an active flare is a reason to pause rather than proceed.
  • Pregnancy. Regenerative therapy is not undertaken during pregnancy.
  • Severe thrombocytopenia (a very low platelet count). This affects clotting and bleeding risk and is a documented contraindication.
  • Uncontrolled medical conditions more broadly, which need to be brought under control first.

These are not hurdles designed to turn people away. They are safeguards. A responsible screening process is meant to protect you, and part of the physician's job is to identify when the risks of proceeding outweigh any potential benefit. Final eligibility is always determined through a comprehensive medical evaluation and diagnostic assessment by the treating physician.

Informed Consent and Screening

Candidacy is not only about tests and categories; it is also about understanding. Pentaheal Medical Group describes a comprehensive screening process before treatment and an informed-consent process as standard parts of care. Informed consent means you receive a clear explanation of what a therapy involves, what is known and not known about it, the possible side effects, and the fact that outcomes are not guaranteed. You should feel free to ask questions until you are comfortable. A good consultation invites this rather than rushing past it.

The clinic reports that, where regenerative treatments are administered, some patients experience temporary side effects. These are described as temporary fatigue in roughly 40 to 60 percent of cases, mild fever within the first 24 hours in about 15 to 20 percent, and a localized injection-site reaction where applicable in about 5 to 10 percent. A rare systemic inflammatory response is reported in fewer than 1 percent of cases. These figures are the clinic's own reported experience and are shared here for transparency, not as a promise about how any individual will respond.

What the FDA Wants Patients to Know

Because regenerative and stem cell products are an area of active regulatory attention, it is worth repeating the essential caution. The U.S. FDA has warned consumers about unapproved stem cell and regenerative products marketed for a wide range of conditions, noting that some have been associated with serious safety concerns and that many claims are not supported by adequate evidence. The FDA has not approved these therapies for effectiveness in the musculoskeletal, inflammatory, or age-related conditions discussed here. This is exactly why a rigorous candidacy process, honest exploratory language, and informed consent matter so much. If you are considering care abroad, bring this framing with you and ask direct questions.

How the Consultation Fits Into Your Overall Journey

At Pentaheal Medical Group, the candidacy evaluation is the front door to any regenerative program, and it is reservation-based with a paid in-person consultation. The clinic also offers virtual consultations before treatment and assigns international patients a dedicated English-speaking coordinator to help with scheduling and communication. Cost and final candidacy are confirmed at consultation rather than promised in advance, and no specific eligibility outcome can be guaranteed before your evaluation is complete. If you would like to begin a conversation or ask about the process, you can reach the team through the contact page.

The Bottom Line

  • Stem cell therapy candidacy is a medical decision made through a structured evaluation, not an assumption based on symptoms alone.
  • Pentaheal Medical Group uses a documented three-step model: a functional health evaluation, precision diagnostic testing, and personalized treatment planning.
  • Documented candidate categories include degenerative joint and musculoskeletal conditions, chronic inflammation or persistent pain, tissue damage or age-related decline, injury or surgery recovery, autoimmune-related conditions considered case by case, and persistent fatigue or metabolic dysfunction.
  • Documented contraindications include active cancer or a cancer history needing evaluation, severe active infection, an autoimmune acute flare, pregnancy, and severe thrombocytopenia; screening and informed consent are standard.
  • These regenerative therapies are not U.S. FDA-approved for effectiveness, outcomes are not guaranteed, results vary, and final eligibility is determined only at physician evaluation.

Frequently Asked Questions

**What are the main criteria physicians use to determine stem cell therapy candidacy?**Physicians look at your medical history, current symptoms, and objective lab results, then weigh them against known contraindications. At Pentaheal Medical Group, this follows a documented three-step model that ends with a personalized plan. The criteria are individualized, so no two evaluations are identical, and eligibility is confirmed only after the full assessment is complete.

**Who qualifies for stem cell therapy at Pentaheal Medical Group?**Documented candidate categories include adults with degenerative joint or musculoskeletal conditions, chronic inflammation or persistent pain, tissue damage or age-related decline, recovery needs after injury or surgery, certain autoimmune-related conditions considered case by case, and persistent fatigue or metabolic dysfunction. Falling into one of these categories means your situation may be evaluated, not that treatment is automatically appropriate.

**What conditions would make someone unsuitable for stem cell therapy?**Documented contraindications include active cancer or a history of cancer requiring further evaluation, severe active infections, certain autoimmune conditions during an acute flare, pregnancy, and severe thrombocytopenia (a very low platelet count). Uncontrolled medical conditions also generally need to be stabilized first. These safeguards protect your safety, and final eligibility is determined by the treating physician.

**What lab tests are used to assess eligibility?**Precision diagnostic testing may include blood and urine analysis, organic acid metabolic analysis, hormone profiling, inflammatory marker testing, food-sensitivity testing, and imaging such as X-ray or bone-density scanning when indicated. The tests evaluate metabolic, nutritional, hormonal, environmental, and inflammatory factors so the physician can judge whether a regenerative approach is both reasonable and safe for you.

**Is stem cell therapy approved by the FDA?**No. Regenerative and mesenchymal stem cell therapies are not approved by the U.S. FDA for effectiveness in the conditions discussed here. Pentaheal Medical Group operates under South Korea's regenerative medicine framework, which is a Korean designation and not equivalent to FDA approval. The FDA has cautioned consumers about unapproved stem cell products, so ask direct questions before proceeding.

**Can I be told I am eligible before my consultation?**No. Final candidacy can only be determined through an in-person physician evaluation and diagnostic assessment. Any preliminary conversation, including a virtual consultation, is helpful for orientation but cannot confirm eligibility, guarantee an outcome, or replace the complete three-step evaluation.

**Does being a candidate guarantee that the therapy will work?**No. Even when someone is assessed as a candidate, outcomes are not guaranteed and individual results vary. The clinic's language about these therapies is exploratory, describing cells as being studied for their potential to support tissue repair. A realistic conversation about expectations is part of the informed-consent process.

**What happens if I am not a candidate?**If a regenerative approach is not appropriate for you, the physician may recommend alternatives grounded in your diagnostic findings, such as physical therapy, medications, other injection-based options, metabolic or nutritional support, or referral for further evaluation. Being screened out of one option is meant to steer you toward safer and more suitable care.

This article is for general informational purposes and does not constitute individualized medical advice. Consult a qualified physician about your specific condition.

More Articles

Continue reading our clinical guides.

View All
Korean Board-Certified Care: Safety in Functional Medicine Standards

Korean Board-Certified Care: Safety in Functional Medicine Standards

Chronic spine, joint, and cancer-related pain affects millions of families across South Korea.

Learn More

Learn More
Functional Medicine Clinic Seoul Korea | PENTAHEAL Guide

Functional Medicine Clinic Seoul Korea | PENTAHEAL Guide

Discover Seoul Korea's top functional medicine clinic for Americans. PENTAHEAL's complete guide to autoimmune, chronic disease and longevity programs in 2026.

Learn More

Learn More
Metabolic Syndrome Treatment Seoul Korea: The PENTAHEAL Protocol

Metabolic Syndrome Treatment Seoul Korea: The PENTAHEAL Protocol

Seeking metabolic syndrome treatment Seoul Korea? PENTAHEAL Medical Group offers a 1:1 metabolic reset program led by Dr. Seok Lee. Book your consult today.

Learn More

Learn More

Medical Clinic

Dedicated to evidence-based medical care, personalized treatment planning, and comprehensive support for local and international patients.

Treatments

SpecialtiesServicesMedical TeamSpecial OffersMedical Articles

Patient Guide

About UsHow It WorksBefore & AfterPatient ReviewsPress & Media

Information & Legal

Contact & LocationSite SearchPrivacy PolicyRefund & Cancellation PolicyTerms of Use

© Medical Clinic. All rights reserved.

Individual clinical results may vary. Please consult a board-certified specialist.